EIO Biomedical

Postsurgical Adhesion Prevention

Health Tech & Life Sciences
Non Active, Jan 2023 ceased to operate
Seed Nazareth, Israel Founded 2016
Last updated 2026-07-16
Total raised
—
Last: Undisclosed Round 2019-01
Stage
Seed
Founded
2016
Headcount
—
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences
LinkedIn ↗

About

EIO Biomedical is a biotechnology company developing a medical device for the prevention of postsurgical adhesions. The device is designed to issue a sprayable adhesion barrier capable of alleviating problems associated with surgical sewing. The company's proprietary device and bioprocess can convert a single unit of blood plasma for infusion, generating a unique enzymatic combination that actively reduces the adhesion-formation process. A disposable kit is provided with the device to ensure that each patient receives a safe and sterile product. The company has recently initiated a first-in-human clinical trial of their FuseX system for the prevention of surgical adhesions on schedule EIO Biomedical is an NGT3 VC portfolio company.

Offices

Nazareth, Israel · HQ / main office

Q&A

What is the current status of EIO Biomedical?
EIO Biomedical is currently inactive, having ceased operations in January 2023.
What was EIO Biomedical's primary focus?
EIO Biomedical focused on developing a medical device for the prevention of postsurgical adhesions, designed to issue a sprayable adhesion barrier.
When was EIO Biomedical founded?
EIO Biomedical was founded in November 2016.
Where is EIO Biomedical headquartered?
EIO Biomedical is headquartered in Nazareth, North District, Israel.
How many employees did EIO Biomedical have?
EIO Biomedical had 1-10 employees.
What was the total amount raised by EIO Biomedical?
EIO Biomedical raised a total of $1,500,000 USD.
When did EIO Biomedical complete its last funding round?
EIO Biomedical completed its last funding round in January 2019, raising $700,000 USD from NGT3 and Israel Innovation Authority.
Which investors participated in EIO Biomedical's June 2017 funding round?
In June 2017, EIO Biomedical received funding from Israel Innovation Authority and NGT3.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

operating-roomssurgery-toolsmedical-technologieshealthcare-providerssurgeryadhesivessurgical-instrumentsmedical-deviceshospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)